Akzo's pharmaceutical sales rise in first half:

Executive Summary

In the first half of 1995, pharma revenues grew 5% at Dutch chemicals, fibres and pharma group Akzo Nobel. Pharma sales, which include Organon Teknika's diagnostics, increased to Fl 1,908 million ($1,066 million). Akzo attributed the growth to volume increases at Organon and its veterinary business. First-half group sales declined 3% to Fl 10,991 million, while net income improved to Fl 789 million compared with Fl 569 million in the previous year.